14 July 2026
Nice wheels! A new kind of vehicle is hitting the road in Mainland China: The Illumina Bioinformatics Mobile Workstation, a traveling bioinformatics solution that brings DRAGEN™-powered high-performance computing closer to scientific and clinical research customers.
Launched last month in Shanghai, the mobile workstation is organized into three functional zones. The laboratory zone features a CNAS-accredited lab that meets international standards for environmental controls, including humidity, temperature, and negative pressure. The computing zone is equipped with 10 built-in DRAGEN V4 servers for secondary analysis. The analysis zone enables on-site, localized data analysis at the customer’s location, fully aligned with China’s national data compliance requirements.
In large-scale cohort studies, bioinformatics solution deployment can be slowed by data localization requirements, compliance obligations, and complex regional rollout processes. This new solution is designed to help overcome those barriers and accelerate the journey from sequencing data to scientific insight.
For researchers in genetics, oncology, drug discovery, and other fields, the solution delivers high-performance mobile computing capacity that remains in short supply in China. It can complete analysis of more than 2,500 human whole genomes at 30× coverage within one week.
Customers run bioinformatics analysis pipelines on their own data. Throughout the process, Illumina does not access or store customer data, helping customers maintain full data sovereignty. Customers without an in-house bioinformatics team can also engage supplementary scientific consulting support as needed.
The mobile bioinformatics analysis platform is the first of its kind in China. “With a customer-centric mindset, Illumina has long been committed to serving customers in China,” says Jenny Zheng, Illumina senior vice president and general manager of Greater China. “Through bioinformatics analysis and advanced multiomic solutions designed to better support frontline needs, together with an expanding local ecosystem of partnerships, Illumina aims to help accelerate the conversion of multiomic data into insights that can support scientific and clinical research. We also look forward to working with more partners across academia, research, and industry in China to advance research and applications in precision medicine."
